Medical Assurance Society NZ Ltd Judgment
Judgment issued against Medical Assurance Society NZ Ltd (MAS).
Use our AI search to ask us a question or use keywords to search for pages or documents.
Example: "How do I apply for a financial institution licence?", "FMA Annual Report 2024"
A filtered search by topic for all guidance, reports or research documents stored on the FMA website.
Judgment issued against Medical Assurance Society NZ Ltd (MAS).
Medical Assurance Society NZ Ltd settlement agreement
Audit Quality Monitoring Report 1 July 2022 – 30 June 2023
The FMA and RBNZ held a webinar in October on the findings from the review with directors of entities that did not participate in the Governance review. All findings are documented in this PDF.
Financial Markets Conduct (Portfolio Superannuation Scheme) Exemption Notice 2023
Financial Markets Conduct (i-Select Superannuation Scheme) Exemption Notice 2023
i Select Superannuation Scheme levy waiver notification 2023
Levy 2023 Portfolio Superannuation Scheme levy waiver notification 2023
Feedback form for Consultation: Fair Outcomes for Consumers and Markets. Submissions close on 1 March 2024
Consultation paper Proposed fair outcomes for consumers and markets, November 2023
Consultation Draft Fair outcomes for consumers and markets: A guide to outcomes-focused regulation (OFR).
This notice is issued under Clause 4 of Schedule 1 of the Financial Markets Infrastructures Act 2021 by the Reserve Bank of New Zealand and the Financial Markets Authority.
FMA makes interim stop order against David McEwen and entities associated with him
This information sheet details compliance expectations of the FMA for scenario analysis disclosures made under the climate-related disclosures (CRD) regime.
Report on findings and areas for improvement identified by the FMA’s 2022 relicensing of Supervisors.